Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

Abroad (travel likely)RecruitingPHASE2

Conditions

Mycosis Fungoides · Lymphomatoid Papulosis · Sezary Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Stanford University Medical Center, Stanford, California, United States
Contact: Study coordinator (Youn Kim, MD) · (650) 498-6000
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Contact: Study coordinator (Alison Moskowitz, MD) · 646-608-3726
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Contact: Study coordinator (Alison Moskowitz, MD) · 646-608-3726
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Contact: Study coordinator (Alison Moskowitz, MD) · 646-608-3726
Memorial Sloan Kettering Commack, Commack, New York, United States
Contact: Study coordinator (Alison Moskowitz, MD) · 646-608-3726
Memorial Sloan Kettering Westchester, East White Plains, New York, United States
Contact: Study coordinator (Alison Moskowitz, MD) · 646-608-3726
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Alison Moskowitz, MD) · 646-608-3726
Contact: Study coordinator (Patricia Myskowski, MD) · 646-608-2351
Contact: Principal Investigator (Alison Moskowitz, MD)
Memorial Sloan Kettering Nassau, Uniondale, New York, United States
Contact: Study coordinator (Alison Moskowitz, MD) · 646-608-3726

Study leads

Alison Moskowitz, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center

View source on ClinicalTrials.gov Contact study team (email)